We wish the FDA well in this evaluation.

There will be plenty who disagree with the final recommendation, no matter what it is.

The Washington Post

“A panel of federal advisers will soon wrestle with a question that has bedeviled poets, philosophers and generations of frustrated men: What do women want?

“That enigma will be part of a Food and Drug Administration committee’s deliberations next month when it considers endorsing the first pill designed to do for women what Viagra did for men: boost their sex lives. A German pharmaceutical giant wants to sell a drug with the decidedly unsexy name “flibanserin,” which has shown prowess for sparking a woman’s sexual desire by fiddling with her brain chemicals. (Emphasis added)

“Even before the FDA’s Reproductive Health Drugs Advisory Committee meets June 18 to consider the request, the prospect of the drug’s approval has triggered debate over whether the medication, like others in the pipeline, represents a long-sought step toward equity for women’s health or the latest example of the pharmaceutical industry fabricating a questionable disorder to sell unnecessary — and potentially dangerous — drugs.” (Emphasis added)

…”In weighing the potential risks and benefits of making flibanserin available by prescription, the FDA committee — its members split evenly between men and women — will have to navigate the subtle terrain of elusive emotional concepts such as desire, arousal, satisfaction and distress.” (Emphasis added)

Source: Washington Post, May 24, 2010